NALM-1/STAT5 Reporter (Luc) stable cell line

NALM-1/STAT5 Reporter (Luc) cells are derived from the human B lymphoblast NALM-1 cell line by stably integration of a STAT5 firefly luciferase reporter construct. The NALM-1 cell line is one of five BCR-ABL1 positive cell lines that are resistant to imatinib-induced apoptosis. NALM-1 cell line is widely used in cancer research, particularly in studies focusing on leukemia and the mechanisms of drug resistance. NALM-1/STAT5 Reporter (Luc) cells stably express firefly luciferase under the control of the STAT5 response elements, can be used for monitoring the activity of STAT5 signaling pathway.